Siga Technologies Inc
(NQ:
SIGA
)
7.210
-0.010 (-0.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
417,653
Open
7.300
Bid (Size)
6.900 (3)
Ask (Size)
7.610 (1)
Prev. Close
7.220
Today's Range
7.155 - 7.510
52wk Range
4.260 - 12.83
Shares Outstanding
71,082,944
Dividend Yield
6.24%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bragar Eagel & Squire, P.C. Is Investigating CSX, Stride, and SIGA and Encourages Investors to Contact the Firm
October 29, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
SIGA ALERT: Bragar Eagel & Squire, P.C. is Investigating SIGA Technologies, Inc. on Behalf of SIGA Stockholders and Encourages Investors to Contact the Firm
October 07, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Performance
YTD
+23.88%
+23.88%
1 Month
+3.30%
+3.30%
3 Month
-12.39%
-12.39%
6 Month
-30.61%
-30.61%
1 Year
+43.06%
+43.06%
More News
Read More
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against SIGA Technologies, Inc. (SIGA)
October 03, 2024
From
Kirby McInerney LLP
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
October 03, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
October 02, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors
October 02, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
August 26, 2024
Via
Benzinga
Government Contract Win May Improve Investor Sentiment For SIGA Tech After Disappointing Trial Data: Analyst
August 23, 2024
Via
Benzinga
Immunome Stock Sees RS Rating Jump To 91
August 20, 2024
Via
Investor's Business Daily
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
August 20, 2024
Via
MarketBeat
Exposures
COVID-19
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
August 19, 2024
Via
Investor's Business Daily
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge
August 19, 2024
Via
Talk Markets
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening
August 19, 2024
Via
Benzinga
Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study
August 16, 2024
Via
Benzinga
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
August 16, 2024
Via
Benzinga
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
August 15, 2024
Via
Benzinga
Exposures
Fossil Fuels
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
August 15, 2024
Via
Benzinga
Russell 2000 Set For Strongest Session In A Month As US Economy Defies Recession Fears: Small Cap Movers On Thursday
August 15, 2024
Via
Benzinga
Topics
ETFs
Economy
Exposures
Economy
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
August 15, 2024
Via
Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
August 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks
August 15, 2024
Via
Benzinga
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
August 14, 2024
Via
Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
August 14, 2024
Via
Benzinga
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
August 06, 2024
Via
FinancialNewsMedia
Exposures
COVID-19
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.